Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
JHS Svendgaard Laboratories Limited (NSE: JHS), ISIN INE544H01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
JHS last traded at ₹8.35 (+3.86%), with a 52-week range of ₹6.26 to ₹13.69 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 33.85%, FIIs 2.87%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 32/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.